ProPublica

Journalism in the Public Interest

Cancel

Prescriber Checkup

At A Glance: This Prescriber in 2012

Family Medicine

Self-Reported Primary Specialty

See Other Prescribers With This Specialty in This State »

7,945Medicare Part D Prescriptions Filled, Including Refills

Rank: 331 out of 1692

$547K Total Retail Price of All Prescriptions

Rank: 207 out of 1692

519 Patients Receiving at Least One Drug in Part D
73%Patients 65 Years and Older
39% Subsidized Claims for Low-Income Patients

How Does This Prescriber Compare to Peers?

In the same specialty and state. Caveats »

Drugs That Present Special Risks
Costs of Prescribing
Higher avg Average for
this specialty
in Virginia
Lower avg

Schedule Two
Controlled Substances

10% of this provider’s 519 patients filled at least one prescription for a schedule two drug, compared to an average of 5%.

Schedule Three
Controlled Substances

9% of this provider’s 519 patients filled at least one prescription for a schedule three drug, compared to an average of 9%.

Risky Drugs to Seniors

1% of this provider’s 5,798 prescriptions for patients 65 and older were for "potentially dangerous" drugs, compared to an average of 1%.

Brand Name Drugs

22% of this provider’s prescriptions were for brand-name drugs, compared to an average of 23%.

Prescription Price

$69 was the average price of a prescription from this provider, compared to $55 among peers.

Prescriptions per Patient

15 is the average number of prescriptions (including refills) per patient, compared to an average of 18.


Another View

This chart shows a different comparison of all providers in this specialty based on their mix of drugs and volume. Providers are grouped by similarity; those least like their peers are farthest to the right. Hover over the bars to see names of other prescribers.

← Prescribers more like their peers Prescribers less like their peers →
KEY: How to read this
chart

Fewer Prescribers
More Prescribers

This Prescriber
Hover to see more prescribers

This Prescriber's Drugs

The table below list this provider’s drugs, the number of prescriptions and how many went to seniors. Drugs are ranked by volume and compared with the rank for all providers in the same specialty and state.

Click to Filter by Category

Clear Filter


S2

A schedule two drug. More » Schedule two drugs have a high potential for abuse and severe dependence, according to the Drug Enforcement Administration.

S3

A schedule three drug. More » Schedule three drugs have potential for abuse and dependence, according to the Drug Enforcement Administration.

A

An antipsychotic drug. More » Antipsychotics are frequently given to dementia patients, though it increases their risk of death.

R

A risky drug for seniors. More » The American Geriatrics Society has said this drug is "potentially dangerous" for seniors and might be inappropriate.

10

This provider is among the top 10 prescribers of
this drug in the country.

This provider’s prescriptions for this drug were for more days than those of peers. More » Because of this, his or her prescription count may be lower.

This provider’s prescriptions for this drug were for fewer days than those of peers. More » Because of this, his or her prescription count may be higher.

This Drug's Rank
Drug Name Total Prescriptions Filled
Including Refills
Prescriptions
to 65+
Category For this Prescriber For All Prescribers in
This Specialty in Virginia
LISINOPRIL 357 260 1 2
SIMVASTATIN 313 240 2 1
OMEPRAZOLE 282 211 3 5
AMLODIPINE BESYLATE 243 212 4 3
FUROSEMIDE 200 169 5 7
HYDROCHLOROTHIAZIDE 187 156 6 9
HYDROCODONE-ACETAMINOPHEN 184 111 S3 7 6
LEVOTHYROXINE SODIUM 175 138 8 4
ATORVASTATIN CALCIUM 158 136 9 11
METOPROLOL TARTRATE 146 113 10 10
ATENOLOL 141 109 11 15
TRAZODONE HCL 135 88 12 33
TRAMADOL HCL 126 44 13 16
GABAPENTIN 123 82 14 13
LOSARTAN POTASSIUM 111 94 15 17
METFORMIN HCL 103 65 16 8
WARFARIN SODIUM 98 88 17 14
POTASSIUM CHLORIDE 96 89 18 20
SERTRALINE HCL 92 71 19 22
METFORMIN HCL ER 90 56 20 49
ZOLPIDEM TARTRATE 82 42 21 23
GLIPIZIDE ER 81 54 22 87
METOPROLOL SUCCINATE 80 57 23 18
SYNTHROID 77 77 24 59
CITALOPRAM HBR 77 59 24 21
LISINOPRIL-HYDROCHLOROTHIAZIDE 72 55 26 19
RANITIDINE HCL 72 70 26 28
NEXIUM 72 48 26 25
CRESTOR 71 47 29 26
FENTANYL 68 58 S2 30 88
ALENDRONATE SODIUM 66 46 31 36
CYMBALTA 64 23 32 51
OXYCONTIN 61 12 S2 33 148
CARVEDILOL 59 52 34 24
DONEPEZIL HCL 55 53 35 29
VENTOLIN HFA 54 22 36 151
FLUTICASONE PROPIONATE 53 44 37 27
OXYCODONE HCL 52 12 S2 38 56
ISOSORBIDE MONONITRATE ER 50 46 39 55
About This Data

ProPublica obtained prescribing data from Medicare’s prescription drug benefit, known as Part D, under the Freedom of Information Act. The data for 2012 includes more than 1.2 billion prescriptions written by nearly 1.5 million doctors, nurses and other providers. This database lists about 382,000 of those providers who wrote 50 or more prescriptions for at least one drug that year. Almost three-fourths went to patients 65 and older; the rest were for disabled patients. Methodology »

Incorrect Info?

If you are a provider and you believe your address is incorrect, check the listing you created on the National Provider Identifier registry. If you change your listing, send a note to drugs@propublica.org and we will update your information. If you have other questions about this data, send a note to drugs@propublica.org.

Caveats
  • No comparisons are shown if 10 or fewer prescribers in the state share this specialty.
  • The list of top drugs includes only those for which this provider wrote 50 or more prescriptions, but all prescriptions are counted in the summary totals at the top.
  • The calculation of “Risky Drugs to Seniors” does not include drugs for which a provider wrote 11 or fewer prescriptions because Medicare redacted the information to protect patient privacy.
  • Comparisons do not take into account the medical conditions of patients. Medications for certain conditions do not have generic alternatives, so patients would receive more expensive brand name drugs.
  • This provider's address and specialty information was last updated on May 14, 2014.
  • Comparisons are based on each provider’s current address, not necessarily where he or she worked during the time period covered in this database.